血液学相关指标在ICU肿瘤患者细菌感染早期诊断中的应用

doi:10.13481/j.1671-587x.20200424

摘要/Abstract

摘要： 目的：测定重症加强护理病房（ICU）肿瘤患者血液学相关指标水平，探讨其在诊断ICU肿瘤患者早期细菌感染中的临床应用。方法：回顾性分析ICU中256例肿瘤患者完整临术资料，根据临床细菌感染标准分为感染组（67例）和非感染组（189例），根据死亡情况分为存活组（193例）和死亡组（63例），测定感染组和非感染组ICU肿瘤患者凝血酶原时间（PT）、活化部分凝血酶原时间（APTT）和D-二聚体（DD）、降钙素原（PCT）水平及白细胞（WBC）、中性粒细胞（NEU）、淋巴细胞（LYM）计数，并计算中性粒细胞/淋巴细胞比值（NLR）。通过受试者工作特征曲线（ROC）和ROC曲线下面积（AUC）评价上述指标诊断ICU肿瘤患者早期细菌感染以及PCT预测ICU早期细菌感染肿瘤患者死亡风险的灵敏度和特异度。结果：与非感染组比较，感染组ICU肿瘤患者PT、APTT、DD、PCT和NLR均明显升高（P<0.05或P<0.01）。与PCT<0.25 μg·L^-1组比较，0.25 μg·L^-1≤PCT<2.00 μg·L^-1、2.00 μg·L^-1≤PCT<10.00 μg·L^-1和PCT≥10.00 μg·L^-1组ICU早期细菌感染肿瘤患者DD和NLR水平均明显升高（P<0.05或P<0.01），2.00 μg·L^-1≤PCT<10.00 μg·L^-1和PCT≥10.00 μg·L^-1组ICU早期细菌感染肿瘤患者PT和APTT均明显升高（P<0.05）。PT、APTT、DD、NLR和PCT诊断ICU肿瘤患者早期细菌感染的AUC、灵敏度和特异度分别为0.636、60.8%和59.1%，0.622、64.6%和58.1%，0.672、69.6%和58.1%，0.752、74.7%和65.6%以及0.855、70.9%和83.9%，差异均有统计学意义（P<0.01）；死亡组ICU早期细菌感染肿瘤患者PCT水平明显高于生存组（P<0.05），PCT预测ICU早期细菌感染肿瘤患者死亡风险的AUC为0.803（95% CI：0.749~0.857），临界（Cut-off）值为6.72 μg·L^-1，灵敏度和特异度分别为63.2%和79.1%，差异有统计学意义（P<0.01）。结论：PT、APTT、DD、PCT和NLR可作为ICU肿瘤患者早期细菌感染的诊断指标，NLR灵敏度最高，PCT特异度最高，PCT可作为ICU早期细菌感染肿瘤患者死亡风险的预测指标。

关键词: 凝血功能指标, 细菌感染, 重症加强护理病房, 肿瘤

Abstract: Objective: To detect the levels of the hematology-related indexes in the tumor patients in intensive care unit(ICU), and to investgate their clinical application in the early diagnosis of bacterial infection in the tumor patients in ICU. Methods: The complete clinical materials of 256 tumor patients in ICU were analyzed retrospectively. According to the clinical bacterial infection standard, they were divided into infection group(67 cases) and non-infection group(189 cases), and according to the situation of death of patients, they were divided into survival group(193 cases) and death group(63 cases). The prothrombin time (PT), active part thrombin time (APTT) and D-Dimer(DD),the levels of procalcitonin (PCT) and the counts of white blood cell(WBC), neutrophile(NEU), lymphocyte(LYM) of the tumor patients in ICU in infection group and non-infection group were measured, and the neutrophile-to-lymphocyte ratio(NLR) was calculated. The sensitivities and specificities of each index in the early diagnosis of bacterial infection in the ICU tumor patients and PCT for predicting the mortality risk in the ICU tumor patients with early bacterial infection were assessed by receiver operating characteristic curve(ROC) and the area under the curve(AUC), and the their clinical values were explored. Results: Compared with non-infection group, the PT, APTT, DD, PCT level and NRL of the ICU tumor patients in infection group were significantly increased(P<0.05 or P<0.01).Compared with PCT<0.25 μg·L^-1 group, the DD and NRL levels of the ICU tumor patients with early bacterial infection in 0.25 μg·L^-1 ≤ PCT<2.00 μg·L^-1 group,2.00 μg·L^-1 ≤ PCT<10.00 μg·L^-1 group and PCT ≥ 10.00 μg·L^-1 group were significantly increased(P<0.05 or P<0.01); the PT and APTT levels of the ICU tumor patients with early bacterial infection in 2.00 μg·L^-1 ≤ PCT<10.00 μg·L^-1 group and PCT ≥ 10.00 μg·L^-1 group were significantly increased(P<0.05).The AUC, sensitivities and specificities of PT, APTT, DD, NLR and PCT in the diagnosis of early bacterial infection in the ICU tumor patients were 0.636, 60.8%, 59.1%; 0.622, 64.6%, 58.1%;0.672, 69.6%, 58.1%;0.752, 74.7%, 65.6%; 0.855, 70.9%, 83.9%; the differences were statistically significant (P<0.01).The PCT level of ICU tumor patients with early bacterial infection in death group was significantly higher than that in survival group (P<0.05).The AUC of PCT for predicting the mortality risk of ICU tumor patients with early bacterial infection was 0.803(95%CI:0.749-0.857), the cut-off value was 6.72 μg·L^-1, the sensitivity and specificity were 63.2% and 79.1%, respectively, and the differences were statistically significant (P<0.01). Conclusion: PT, APTT, DD, PCT and NLR can be used as the early diagnostic indicators of bacterial infection in the ICU tumor patients. The sensitivity of NLR and the specificity of PCT were the highest. PCT can be used as a predictor of the mortality risk in the ICU tumor patients with early bacterial infection.

Key words: coagulation function index, bacterial infection, intensive care unit, tumor

中图分类号:

R730.43

李铤, 陈媛媛, 孙洪帅, 于秀艳, 吴雪峰. 血液学相关指标在ICU肿瘤患者细菌感染早期诊断中的应用[J]. 吉林大学学报(医学版), 2020, 46(04): 816-821.

LI Ting, CHEN Yuanyuan, SUN Hongshuai, YU Xiuyan, WU Xuefeng. Application of hematology-related indexes in early diagnosis of bacterial infectionof tumor patients in ICU[J]. Journal of Jilin University(Medicine Edition), 2020, 46(04): 816-821.

参考文献

[1] 胡芸芸, 王江波.降钙素原指导ICU危重患者抗菌治疗的临床价值[J]. 中外女性健康研究, 2016(16):160, 162.
[2] 任乐宁, 夏征. ICU脓毒血症者凝血功能及炎症因子相关性分析[J]. 现代医用影像学, 2018, 27(5):1815-1816.
[3] 丁政,顾小宇.ICU感染患者凝血障碍与脓毒症严重程度的关系探讨[J].中外医疗,2019,38(1):49-50,167.
[4] SAR R, KARAKURT Z, AY M, et al. Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit[J]. Turk J Med Sci, 2019, 49(5):1336-1349.
[5] YANG B, WANG J Q, TAO X G, et al. Clinical investigation on the risk factors for prognosis in patients with septic shock[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, 31(9):1078-1082.
[6] WARKENTIN T E, AIRD W C, RAND J H. Platelet-endothelial interactions:sepsis, HIT, and antiphospholipid syndrome[J]. Hematol Am Soc Hematol Educ Program, 2003, 2003:497-519.
[7] GUO X Q, LIU Y H, LI D, et al. Plasma thrombomodulin levels are associated with endothelial injury in patients with bacterial infections[J]. Clin Lab, 2019. DOI:10.7754/Clin.Lab.2019.190134.
[8] 刘乐乐,李华.中性粒细胞和淋巴细胞VCS参数与NLR对肿瘤患者化疗后细菌感染辅助诊断价值[J].中华肿瘤防治杂志,2019,26(3):190-193.
[9] 李宁, 孙文伟, 赵建军, 等. 血清降钙素原在社区获得性肺炎诊治中的临床应用价值[J]. 吉林大学学报(医学版), 2015, 41(2):352-355.
[10] WANG H D. Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019, 31(8):962-966.
[11] BOZKAYA D, YIGIT Ş, YURDAKOK M. Is serum procalcitonin level a reliable indicator in early diagnosis of congenital pneumonia?[J]. Turk J Pediatr, 2019, 61(1):34-39.
[12] ASSINK-DE JONG E, DE LANGE D W, VAN OERS J A,et al. Stop Antibiotics on guidance of Procalcitonin Study (SAPS):a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients:calculated sample size:1816 patients[J]. BMC Infect Dis, 2013, 13:178.
[13] SPOTO S, FOGOLARI M, DE FLORIO L, et al. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock[J]. Microb Pathog, 2019, 137:103763.
[14] JEKARL D W, LEE S, KIM M, et al. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3[J]. J Clin Lab Anal, 2019, 33(9):e22996.
[15] 刘阳桦, 吴敏. 细菌性血流感染所致脓毒症患者凝血-炎症生物标志物水平变化的临床意义[J]. 中国病原生物学杂志, 2017, 12(3):270-273.
[16] 洪峰,周大勇.降钙素原、血小板及D-二聚体检测在脓毒症预后中的价值[J].蚌埠医学院学报,2018,43(11):1471-1473.
[17] 门学千,李贺明,董茜,等.肿瘤内科住院患者静脉血栓危险因素分析及现有风险评估模型预测价值研究[J].中国实用内科杂志,2019,39(8):694-697.
[18] 曲远青, 刘涛, 刘媛, 等. 不同病程的细菌性炎症患者中降钙素原与凝血功能指标的相关性分析[J]. 免疫学杂志, 2015, 31(5):417-420.
[19] 陈崇,周桃玉,温旺荣.中性粒细胞/淋巴细胞计数与降钙素原对肿瘤患者合并细菌感染的诊断价值[J].现代肿瘤医学,2019,27(10):1786-1788.
[20] 王宁, 刘利胜. 降钙素原与中性粒细胞和淋巴细胞计数比值对肿瘤患者细菌感染预测价值[J]. 中华肿瘤防治杂志, 2018, 25(8):595-598.
[21] SONG J, PARK D W, MOON S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients:a prospective controlled study according to the Sepsis-3 definitions[J]. BMC Infect Dis, 2019, 19(1):968.
[22] 卓慧, 范中红, 徐琛. 降钙素原指导ICU危重患者抗菌治疗的临床价值[J]. 世界最新医学信息文摘, 2019, 19(69):205-206.
[23] SEN P, DEMIRDAL T, NEMLI S A, et al. Diagnostic and prognostic value of new bioscore in critically ill septic patients[J]. Arch Physiol Biochem, 2019, 2019(5):1-6.
[24] 付守芝,曹松,叶先智,等.血液净化治疗对脓毒血症患者降钙素原、C反应蛋白及疗效的影响[J]. 中国实用内科杂志,2019,38(增刊2):80-82.
[25] WINEBERG D, MOORE R, KRUGER D. Procalcitonin and bacterial sepsis in burn patients in south Africa[J]. J Surg Res, 2020, 246:490-498.
[26] 陈淼, 林晓军, 张红璇, 等. ICU医院感染患者病原菌分布特点及血清PCT变化与预后临床价值分析[J]. 中华医院感染学杂志, 2017, 27(13):2951-2953, 2960.